Detalhe da pesquisa
1.
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
N Engl J Med
; 387(11): 978-988, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036525
2.
Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.
Circulation
; 147(13): 1004-1013, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802715
3.
Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III.
Circulation
; 148(17): 1298-1304, 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732457
4.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
N Engl J Med
; 385(10): 896-907, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215025
5.
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial.
Diabetes Obes Metab
; 26(4): 1180-1187, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204215
6.
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial.
Diabetes Obes Metab
; 26(4): 1216-1223, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116691
7.
Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.
Ann Intern Med
; 176(10): 1299-1307, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782930
8.
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial.
Circulation
; 145(8): 565-574, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775781
9.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996147
10.
Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort.
J Cardiovasc Magn Reson
; 24(1): 2, 2022 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980185
11.
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.
Lancet
; 396(10256): 968-976, 2020 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010842
12.
21st-century hazards of smoking and benefits of cessation in the United States.
N Engl J Med
; 368(4): 341-50, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343063
13.
Suicide mortality in India: a nationally representative survey.
Lancet
; 379(9834): 2343-51, 2012 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22726517
14.
Cancer mortality in India: a nationally representative survey.
Lancet
; 379(9828): 1807-16, 2012 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22460346
15.
Smoking-attributable mortality in Bangladesh: proportional mortality study.
Bull World Health Organ
; 91(10): 757-64, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24115799
16.
Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease.
Eur J Prev Cardiol
; 30(7): 535-545, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444513
17.
Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.
Eur J Prev Cardiol
; 30(8): 709-718, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080912
18.
Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials.
Cardiovasc Res
; 118(3): 897-903, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33705531
19.
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
J Clin Endocrinol Metab
; 107(8): e3448-e3454, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35446415
20.
Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial.
Atherosclerosis
; 331: 38-44, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340829